PulseMedica
AB - EdmontonBiotechnology
Focus: PulseMedica is a publicly-traded biotechnology company headquartered in Edmonton, Alberta, focused on vitreoretinal screening and ophthalmology solutions. The company operates at a small scale with a lean pipeline targeting unmet needs in retinal disease.
Profile data last refreshed 20h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
3+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at PulseMedica?
AI assessmentPulseMedica is a speculative public-stage ophthalmology biotech with high individual impact potential but significant execution and data transparency risks—suitable only for risk-tolerant specialists seeking niche expertise.
Why Work Here
- Focused specialist in ophthalmology with a targeted approach to vitreoretinal disease, offering clarity on therapeutic direction
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
SVO-ID
FloatersClinical Trials (1)
NCT06097897Imaging of Vitreous Opacities in Human Eyes
N/AHelp build intelligence for PulseMedica
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.